stockrowCelcuity, Inc. (CELC) vs Tarsus Pharmaceuticals, Inc. (TARS)
- Celcuity, Inc. CELC 66.30 +3.53%
- Tarsus Pharmaceuticals, Inc. TARS 67.49 −0.04%
Celcuity, Inc. and Tarsus Pharmaceuticals, Inc. are both Biotechnology companies. Celcuity, Inc. and Tarsus Pharmaceuticals, Inc. are of similar size ($3.3B and $3.1B). Celcuity, Inc. has the higher net margin (0.00% vs −102.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Celcuity, Inc. leads on 7 and Tarsus Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | CELC | TARS | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 93.21% | 65.16% |
| Operating margin | 0.00% | (102.04%) | 0.00% |
| Net margin | 0.00% | (102.93%) | 0.00% |
| Free cash flow margin | 0.00% | 4.76% | 0.00% |
| Return on equity | (1,433.70%) | (319.84%) | (50.12%) |
| Return on assets | (44.77%) | (135.04%) | (45.60%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack